From tissue to technology: how AI is reshaping cancer research and diagnostics. 🧬📊🧠
At the AI-Driven Cancer Research panel at the
@JohnsHopkins Science Diplomacy Summit 2025, speakers explored how digital pathology and machine learning are transforming early detection, treatment prediction, and health equity.
Dr. Hugues Berry, Head of
@Inserm’s Office for AI and Digital Sciences, shared how AI can diagnose skin lesions more accurately than trained dermatologists—enabling earlier, at-home cancer screening via smartphone. 📱
Dr. Alex Baras, Director of Computational Pathology & Informatics and Associate Professor at
@HopkinsMedicine, discussed how digitized pathology slides paired with AI are improving diagnostic precision, accelerating workflows, and expanding global collaboration.
Moderator Mireille Guyader, Counselor for Science and Technology at the Embassy of France in the U.S. (
@franceintheus,
@francescience), raised critical questions around data interpretability, and accessibility.
Key takeaway:
AI isn’t replacing doctors. It’s amplifying their reach, precision, and ability to personalize care—especially when built with transparency and real-world context in mind.
#AIinHealthcare #CancerResearch #DigitalPathology #ScienceDiplomacy #Innovation #GlobalHealth #HealthEquity #AIEthics #MedicalAI #HigherEd #STEMLeadership